Muscle-selective hybrid regulatory combinations and methods of using these for the treatment of type 1 myotonic dystrophy
CO20260010236A2Pending Publication Date: 2026-07-31ASTELLAS GENE THERAPIES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- ASTELLAS GENE THERAPIES INC
- Filing Date
- 2026-07-15
- Publication Date
- 2026-07-31
Abstract
Combinations of muscle-selective promoters and RNA-targeted gene therapy compositions, as well as methods comprising them, are described for the treatment of DM1.
Need to check novelty before this filing date? Find Prior Art